Moringa Frontiers Private Limited

Moringa Frontiers Private Limited

Provides clinical research services for pharmaceutical and biotech product development.
2018 | Mumbai, Maharashtra (India) | Active

Last Updated:

November 04, 2024
HomeCompanyMoringa Frontiers Private Limited

Who are the key members and board of directors at Moringa Frontiers?

Board Members(2)

NameDesignationAppointment DateStatus
Ahila Venkatraman In Director 16-Feb-2018Current
Ravindra Gulgule In Director 16-Feb-2018Current

Financial Performance of Moringa Frontiers.

Moringa Frontiers Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.51% increase. The company also saw a substantial improvement in profitability, with a 110.62% increase in profit. The company's net worth moved up by a moderate rise of 7.25%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
107.51%
Revenue from Operations
106.45%
Total Assets
102.13%
Profit or Loss
110.62%
Net Worth
7.25%
EBITDA
107.74%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Moringa Frontiers?

Moringa Frontiers has a workforce of 16 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Moringa Frontiers

Recent activity within the organization

  • Annual General Meeting

    Moringa Frontiers Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Moringa Frontiers Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Director Appointment

    Ravindra Ramakant Gulgule was appointed as a Director was appointed as a Director on 16 Feb 2018 & has been associated with this company since 6 years 10 months .

    16 Feb 2018

  • Director Appointment

    Ahila Venkatraman was appointed as a Director was appointed as a Director on 16 Feb 2018 & has been associated with this company since 6 years 10 months .

    16 Feb 2018

  • Company Incorporation

    Moringa Frontiers Private Limited was registered on 16 Feb 2018 with Roc Mumbai & aged 6 years 10 months as per MCA records.

    16 Feb 2018

Frequently asked questions

  • Moringa Frontiers Private Limited was incorporated on 16 Feb 2018.

  • The authorized share capital of Moringa Frontiers Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Moringa Frontiers Private Limited.

    • Ahila Venkatraman
    • Ravindra Ramakant Gulgule
  • As per Ministry of Corporate Affairs (Mca), the registered address of Moringa Frontiers Private Limited is 36 Floor 3 Plot 277 B-2 Bmc Officers Jamshedji Road Sitalata Devi, Mahim India, Mumbai, Maharashtra, 400016.

  • The corporate identification number (CIN) of Moringa Frontiers Private Limited is U74999MH2018PTC305147 and the company number is 305147 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Moringa Frontiers Private Limited is https://www.moringafrontiers.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Moringa Frontiers Private Limited has risen by 107.51%.

  • As Per 2023 financial reports, 16 employees are currently employed by Moringa Frontiers Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Moringa Frontiers Private Limited has experienced an upsurge of 7.25%.

  • The most recent Balance Sheet for Moringa Frontiers Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Pharma Contract R&D